MedImmune Inc., which officially put itself up for sale less than two weeks ago, agreed Monday to be acquired by AstraZeneca plc for $15.2 billion. (BioWorld Today)
MedImmune Inc., which officially put itself up for sale less than two weeks ago, agreed Monday to be acquired by AstraZeneca plc for $15.2 billion. (BioWorld Today)